Antibody Characterization Report for Sigma non-opioid intracellular receptor 1
Head-to-head comparison of available commercial antibodies against Sigma non-opioid intracellular receptor 1 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported by the ALS-Reproducible Antibody Platform (ALS-RAP), a public-private partnership established by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
Sigma non-opioid intracellular receptor 1_SIGMAR1-YCharOS report.pdf